title: The use of a chromogenic assay for factor VIII in patients with factor VIII inhibitors or von Willebrand's disease.
authors.affiliation: Haemophilia Centre, Royal Free Hospital, London, UK.
authors.forename: R A
authors.initials: RA
authors.lastname: Hutton
authors.forename: A
authors.initials: A
authors.lastname: Kamiguti Yamaga
authors.forename: K B
authors.initials: KB
authors.lastname: Matthews
authors.forename: B J
authors.initials: BJ
authors.lastname: Woodhams
mesh_terms: D001323:Autoantibodies / Q000097:blood; D001681:Biological Assay / Q000379:methods; D001774:Blood Chemical Analysis / Q000379:methods*; D002863:Chromogenic Compounds; D005069:Evaluation Studies as Topic; D005169:Factor VIII / Q000032:analysis* / Q000037:antagonists & inhibitors / Q000276:immunology; D005260:Female; D006801:Humans; D008297:Male; D014842:von Willebrand Diseases / Q000097:blood*
chemical_list: D001323:Autoantibodies; D002863:Chromogenic Compounds; D005169:Factor VIII